Structural properties of solid lipid based colloidal drug delivery systems

Current Opinion in Colloid and Interface Science

Volumn 16, Issue 5, 2011, Pages 405-411

  Bunjes, Heike ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Colloidal drug carrier systems; Crystallization; Glycerides; Polymorphism; Solid lipid nanoparticles

Indexed keywords

COLLOIDAL DRUG CARRIERS; COLLOIDAL STATE; CRYSTALLIZATION BEHAVIOR; DRUG CARRIER; DRUG CARRIER SYSTEMS; DRUG DELIVERY SYSTEM; GLYCERIDES; INDIVIDUAL PARTICLES; LIPID MATRIX; MACROSCOPIC BEHAVIORS; MATERIAL PROPERTY; MATRIX; NANOPARTICULATE SYSTEM; PARTICLE SHAPE; POLYMORPHIC TRANSITIONS; RHEOLOGICAL PROPERTY; SOLID LIPID NANOPARTICLES; STRUCTURAL CHARACTERISTICS; STRUCTURAL PARAMETER;

CRYSTALLIZATION; DISPERSIONS; DRUG DELIVERY; FATTY ACIDS; LIPIDS; NANOPARTICLES; POLYMORPHISM; RHEOLOGY; SURFACE ACTIVE AGENTS;

STRUCTURAL PROPERTIES;

ACYLGLYCEROL; SOLID LIPID NANOPARTICLE; SURFACTANT; TRIACYLGLYCEROL;

COLLOID; CRYSTALLIZATION; DISPERSION; DRUG DELIVERY SYSTEM; ELECTRON SPIN RESONANCE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PROTEIN POLYMORPHISM; REVIEW;

EID: 80052854046     PISSN: 13590294     EISSN: 18790399     Source Type: Journal    
DOI: 10.1016/j.cocis.2011.06.007     Document Type: Review

References (55)

1. Devalapally H., Chakilam A., Amiji M.M. Role of nanotechnology in pharmaceutical product development. J Pharm Sci 2007, 96:2547-2565.
2. Bunjes H. Lipid nanoparticles for the delivery of poorly water soluble drugs. J Pharm Pharmacol 2010, 62:1637-1645.
3. Mehnert W., Mäder K. Solid lipid nanoparticles. Production, characterization and applications. Adv Drug Deliv Rev 2001, 47:165-196.
4. Bunjes H., Westesen K., Koch M.H.J. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 1996, 129:159-173.
5. Westesen K., Bunjes H., Koch M.H.J. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 1997, 48:223-236.
6. 1H NMR). Colloids Surf B 2010, 77:286-297.
7. Bunjes H., Westesen K. Influences of colloidal state on physical properties of solid fats. Crystallization processes in fats and lipid systems 2001, 457-483. Marcel Dekker, New York. N. Garti, K. Sato (Eds.).
8. Lim S., Kim C.K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002, 243:135-146.
9. Higami M., Ueno S., Segawa T., Iwanami K., Sato K. Simultaneous synchrotron radiation X-ray diffraction-DSC analysis of melting and crystallization behavior of trilauroylglycerol in nanoparticles of oil-in-water emulsion. J Am Oil Chem Soc 2003, 80:731-739.
10. Bunjes H., Drechsler M., Koch M.H.J., Westesen K. Incorporation of the model drug ubidecarenone into solid lipid nanoparticles. Pharm Res 2001, 18:287-293.
11. Awad T.S., Helgason T., Weiss J., Decker E.A., McClements D.J. Effect of Omega-3 fatty acids on crystallization, polymorphic transformation and stability of tripalmitin solid lipid nanoparticle suspensions. Cryst Growth Des 2009, 9:3405-3411.
12. Jenning V., Thünemann A.F., Gohla S.H. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000, 199:167-177.
13. ®): drug-lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm 2008, 68:535-544.
14. Blümer C., Mäder K. Isostatic ultra-high-pressure effects on supercooled melts in colloidal triglyceride dispersions. Pharm Res 2005, 22:1708-1715.
15. Bunjes H., Koch M.H.J., Westesen K. Effects of surfactants on the crystallization and polymorphism of lipid nanoparticles. Prog Colloid Polym Sci 2002, 121:7-10.
16. Bunjes H., Koch M.H.J. Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. J Control Release 2005, 107:229-243.
17. Awad T.S., Sato K. Fat crystallization in O/W emulsions controlled by hydrophobic emulsifier additives. Physical properties of lipids 2002, 37-62. Marcel Dekker, New York. A.G. Marangoni, S.S. Narine (Eds.).
18. Sonoda T., Takata Y., Ueno S., Sato K. Effects of emulsifiers on crystallization behavior of lipid crystals in nanometer-size oil-in-water emulsion droplets. Cryst Growth Des 2006, 6:306-312.
19. Arima S., Ueno S., Ogawa A., Sato K. Scanning microbeam small-angle X-ray diffraction study of interfacial heterogeneous crystallization of fat crystals in oil-in-water emulsion droplets. Langmuir 2009, 25:9777-9784.
20. Freitas C., Müller R.H. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm 1999, 47:125-132.
21. Westesen K., Drechsler M., Bunjes H. Colloidal dispersions based on solid lipids. Food colloids: fundamentals of formulation 2001, 103-115. Royal Society of Chemistry, Cambridge. E. Dickinson, R. Miller (Eds.).
22. Jenning V., Schäfer-Korting M., Gohla S.H. Vitamin A loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 2000, 66:115-126.
23. Jores K., Mehnert W., Mäder K. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study. Pharm Res 2003, 20:1274-1283.
24. Schubert M.A., Schicke B.C., Müller-Goymann C.C. Thermal analysis of the crystallization and melting behavior of lipid matrices and lipid nanoparticles containing high amounts of lecithin. Int J Pharm 2005, 298:242-254.
25. Bunjes H., Koch M.H.J., Westesen K. Effect of particle size on colloidal solid triglycerides. Langmuir 2000, 16:5234-5241.
26. Petersen S., Fahr A., Bunjes H. Flow cytometry as a new approach to investigate drug transfer between lipid particles. Mol Pharmaceutics 2010, 7:350-363. (and supporting information).
27. Bunjes H., Koch M.H.J., Westesen K. Influence of emulsifiers on the crystallization of solid lipid nanoparticles. J Pharm Sci 2003, 92:509-1520.
28. Bunjes H., Steiniger F., Richter W. Visualizing the structure of triglyceride nanoparticles in different crystal modifications. Langmuir 2007, 23:4005-4011.
29. Rosenblatt K.M., Bunjes H. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the α-modification. Mol Pharmaceutics 2009, 6:105-120.
30. Westesen K., Siekmann B. Investigation of the gel formation of phospholipid stabilized solid lipid nanoparticles. Int J Pharm 1997, 151:35-45.
31. Unruh T., Bunjes H., Westesen K., Koch M.H.J. Observation of size-dependent melting in lipid nanoparticles. J Phys Chem B 1999, 103:10373-10377.
32. Illing A., Unruh T. Investigations on the flow behavior of dispersions of solid triglyceride nanoparticles. Int J Pharm 2004, 284:123-131.
33. Illing A., Unruh T., Koch M.H.J. Investigation on particle self-assembly in solid lipid based colloidal drug carrier systems. Pharm Res 2004, 21:592-597.
34. Unruh T., Westesen K., Bösecke P., Lindner P., Koch M.H.J. Self-assembly of triglyceride nanocrystals in suspension. Langmuir 2002, 18:1796-1800.
35. Jores K., Mehnert W., Drechsler M., Bunjes H., Johann C., Mäder K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release 2004, 95:217-227.
36. Schubert M.A., Harms M., Müller-Goymann C.C. Structural investigations on lipid nanoparticles containing high amounts of lecithin. Eur J Pharm Sci 2006, 27:226-236.
37. Schubert M.A., Müller-Goymann C.C. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm 2005, 61:77-86.
38. Esposito E., Fantin M., Marti M., Drechsler M., Paccamiccio L., Mariani P., et al. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm Res 2007, 25:1521-1530.
39. Garcia-Fuentes M., Alonso M.J., Torres D. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. J Colloid Interface Sci 2005, 285:590-598.
40. Jores K., Haberland A., Wartewig S., Mäder K., Mehnert W. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. Pharm Res 2005, 22:1887-1897.
41. Garcia-Fuentes M., Torres D., Martín-Pastor M., Alonso M.J. Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles. Langmuir 2004, 20:8839-8845.
42. Unruh T., Bunjes H., Westesen K., Koch M.H.J. Investigations on the melting behaviour of triglyceride nanoparticles. Colloid Polym Sci 2001, 279:398-403.
43. Unruh T. Interpretation of small-angle X-ray scattering patterns of crystalline triglyceride nanoparticles in dispersion. J Appl Cryst 2007, 40:1008-1018.
44. Lippacher A., Müller R.H., Mäder K. Investigation on the viscoelastic properties of lipid based colloidal drug carriers. Int J Pharm 2000, 196:227-230.
45. Lippacher A., Müller R.H., Mäder K. Semisolid SLN dispersions for topical application: influence of the formulation and production parameters on viscoelastic properties. Eur J Pharm Biopharm 2002, 53:155-160.
46. Freitas C., Müller R.H. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions. Int J Pharm 1998, 168:221-229.
47. Helgason T., Awad T.S., Kristbergsson K., McClements D.J., Weiss J. Influence of polymorphic transformations on gelation of tripalmitin solid lipid nanoparticle suspensions. J Am Oil Chem Soc 2008, 85:501-511.
48. Ghosh S., Peterson D.G., Coupland J.N. Temporal aroma release profile of solid and liquid droplet emulsions. Food Biophys 2008, 3:335-343.
49. Ahlin P., Kristl J., Šentjurc M., Štrancar J., Pečar S. Influence of spin probe structure on its distribution in SLN dispersions. Int J Pharm 2000, 196:241-244.
50. Braem C., Blaschke T., Panek-Minkin G., Herrmann W., Schlupp P., Paepenmüller T., et al. Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. J Control Release 2007, 119:128-135.
51. Sivaramakrishnan R., Nakamura C., Mehnert W., Korting H.C., Kramer K.D., Schäfer-Korting M. Glucocorticoid entrapment into lipid carriers-characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Release 2004, 97:493-502.
52. Garcia-Fuentes M., Torres D., Alonso M.J. New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int J Pharm 2005, 296:122-132.
53. Tabatt K., Sameti M., Olbrich C., Müller R.H., Lehr C.M. Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer. Eur J Pharm Biopharm 2004, 57:155-162.
54. Wissing S.A., Müller R.H. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release 2002, 81:225-233.
55. Zur Mühlen A., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur J Pharm Biopharm 1998, 45:149-155.